Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
J Clin Oncol. 2022 Sep 1;40(25):2946-2956. doi: 10.1200/JCO.21.02772. Epub 2022 Jun 28.
J Clin Oncol. 2022.
PMID: 35763704
Free PMC article.
Clinical Trial.
Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers.
Srivastava P, Wang T, Clark BZ, Yu J, Fine JL, Villatoro TM, Carter GJ, Brufsky AM, Gorantla VC, Huggins-Puhalla SL, Emens LA, Basili T, da Silva EM, Reis-Filho JS, Bhargava R.
Srivastava P, et al. Among authors: huggins puhalla sl.
NPJ Breast Cancer. 2022 Apr 20;8(1):51. doi: 10.1038/s41523-022-00415-z.
NPJ Breast Cancer. 2022.
PMID: 35444182
Free PMC article.
Item in Clipboard
Cite
Cite